Wahner Hendrickson, A. E. (2018). A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationWahner Hendrickson, A. E. A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationWahner Hendrickson, A. E. A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.